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DISCUSSION
Dr R. James Valentine (Dallas, Texas). The purpose of this
study was to determine the incidence and natural history of inci-
dental renal artery stenoses in the general population of elderly
patients. The study methods are sound, and the excellent technical
results are commendable. Vascular surgeons should take note of
the criterion used to define a hemodynamically significant renal
artery stenosis. A peak systolic velocity of 1.8 m/s or more was
chosen after many years of laboratory and clinical investigation,
and it has been validated with renal arteriography. The Wake
Forest group has one of the largest experiences with renal artery
disease in the United States. The fact that 99% of their scans were
technically satisfactory attests to their expertise in renal artery
ultrasound.
The authors did a nice job of sampling the elderly population
in the initial study, and recruiting limitations are acknowledged in
themanuscript. However, only 14% of the original cohort returned
for the second renal artery duplex examination, which represents
less than 20% of the survivors in the Cardiovascular Health Study.
This brings me to my first question: what happened to the other
80%? After 8 years, important differences may have emerged be-
tween the recruited and non-recruited subjects, challenging the
notion that the study subjects represent the general population.
My second question relates to the 224 subjects who died after
the initial study. At this meeting 13 years ago, we reported that
incidental renal artery stenoses represent a marker for coronary
artery disease in vascular patients. Did the deceased subjects have a
higher incidence of renal artery disease than the survivors?
The take-home message from the present data is this: if you
find an incidental renal artery stenosis in an elderly patient, leave it
alone. Few lesions will progress. New, hemodynamically significant
lesions can be expected to develop in less than 5% of patients.
However, new lesions were significantly associated with an increase
in diastolic blood pressure and a decrease in renal length. This
brings me to my final question: could the affected patients have
been identified on the basis of worsening hypertension or rising
creatinine?
Dr Jeffrey Pearce. We practice and believe the results of the
study support the continued observation and not intervention for
incidentally found asymptomatic renal artery lesions, particularly in
those patients with normal or well-controlled blood pressure and
preserved renal function.
With regard to your first question, you correctly noted that
80% of the surviving participants did not return for a second
duplex. With the use of our institution’s GCRC, we attempted to
contact all surviving participants. Unfortunately with closure of the
CHS and lack of further annual follow-up exams, some of the
contact information was inaccurate. Furthermore, many of these
octogenarians are now living in nursing facilities, limiting their
ability to participate in the exam.
Regarding the question on the prevalence of RVD in those
surviving participants, I cannot give you a definitive answer but I
might be able to shed some light on the issue. We have previously
reported a twofold increase of subsequent cardiovascular events in
participants with RVD, even when controlling for prevalent car-
diovascular risk factors. Though the presence of RVD did not
confer an overall survival disadvantage, we believe these partici-
pants are having more cardiac events. Thus, some of them may
have succumbed in the study interval due to cardiac disease.
And then finally with regard to your question on patient
screening for duplex examinations, we looked critically at those
participants that had RVD in this cohort and none of these
participants smelled of renovascular disease. None of them had
severe hypertension. None of them had renal insufficiency. There-
fore, none of these participants would have met our screening
criteria, which is for those folks with worsening uncontrolled or
severe hypertension or with progressive renal insufficiency.
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